Literature DB >> 22195564

Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.

Aaron J Tyznik1, Elisa Farber, Enrico Girardi, Alysia Birkholz, Yali Li, Sampada Chitale, Regina So, Pooja Arora, Archana Khurana, Jing Wang, Steven A Porcelli, Dirk M Zajonc, Mitchell Kronenberg, Amy R Howell.   

Abstract

Natural killer T (NKT) cells recognize glycolipids presented by CD1d. The first antigen described, α-galactosyl ceramide (αGalCer), is a potential anticancer agent whose activity depends upon IFN-γ secretion. We report two analogs of αGalCer based on a naturally occurring glycosphingolipid, plakoside A. These compounds induce enhanced IFN-γ that correlates with detergent-resistant binding to CD1d and an increased stability of the lipid-CD1d complexes on antigen-presenting cells. Structural analysis on one of the analogs indicates that it is more deeply bound inside the CD1d groove, suggesting tighter lipid-CD1d interactions. To our knowledge, this is the first example in which structural information provides an explanation for the increased lipid-CD1d stability, likely responsible for the Th1 bias. We provide insights into the mechanism of IFN-γ-inducing compounds, and because our compounds activate human NKT cells, they could have therapeutic utility.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22195564      PMCID: PMC3246403          DOI: 10.1016/j.chembiol.2011.10.015

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  49 in total

1.  Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.

Authors:  Masakazu Fujio; Douglass Wu; Raquel Garcia-Navarro; David D Ho; Moriya Tsuji; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2006-07-19       Impact factor: 15.419

2.  Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.

Authors:  Aaron J Tyznik; Emmanuel Tupin; Niranjana A Nagarajan; Min J Her; Chris A Benedict; Mitchell Kronenberg
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.

Authors:  Kwok S Wun; Garth Cameron; Onisha Patel; Siew Siew Pang; Daniel G Pellicci; Lucy C Sullivan; Santosh Keshipeddy; Mary H Young; Adam P Uldrich; Meena S Thakur; Stewart K Richardson; Amy R Howell; Petr A Illarionov; Andrew G Brooks; Gurdyal S Besra; James McCluskey; Laurent Gapin; Steven A Porcelli; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

4.  Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Authors:  Daniel G Pellicci; Onisha Patel; Lars Kjer-Nielsen; Siew Siew Pang; Lucy C Sullivan; Konstantinos Kyparissoudis; Andrew G Brooks; Hugh H Reid; Stephanie Gras; Isabelle S Lucet; Ruide Koh; Mark J Smyth; Thierry Mallevaey; Jennifer L Matsuda; Laurent Gapin; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition.

Authors:  Stéphane Sidobre; Kirsten J L Hammond; Lise Bénazet-Sidobre; Sergei D Maltsev; Stewart K Richardson; Rachel M Ndonye; Amy R Howell; Teruyuki Sakai; Gurdyal S Besra; Steven A Porcelli; Mitchell Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

7.  Efficient, one-pot syntheses of biologically active alpha-linked glycolipids.

Authors:  Wenjun Du; Suvarn S Kulkarni; Jacquelyn Gervay-Hague
Journal:  Chem Commun (Camb)       Date:  2007-06-21       Impact factor: 6.222

8.  The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Authors:  H Kitamura; K Iwakabe; T Yahata; S Nishimura; A Ohta; Y Ohmi; M Sato; K Takeda; K Okumura; L Van Kaer; T Kawano; M Taniguchi; T Nishimura
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

9.  Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.

Authors:  Jin S Im; Pooja Arora; Gabriel Bricard; Alberto Molano; Manjunatha M Venkataswamy; Ian Baine; Elliot S Jerud; Michael F Goldberg; Andres Baena; Karl O A Yu; Rachel M Ndonye; Amy R Howell; Weiming Yuan; Peter Cresswell; Young-Tae Chang; Petr A Illarionov; Gurdyal S Besra; Steven A Porcelli
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

10.  Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.

Authors:  Karl O A Yu; Jin S Im; Petr A Illarionov; Rachel M Ndonye; Amy R Howell; Gurdyal S Besra; Steven A Porcelli
Journal:  J Immunol Methods       Date:  2007-04-05       Impact factor: 2.303

View more
  24 in total

Review 1.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

Review 2.  Invariant natural killer T cells and their ligands: focus on multiple sclerosis.

Authors:  Joan O'Keeffe; Maria Podbielska; Edward L Hogan
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

3.  Distinct requirements for activation of NKT and NK cells during viral infection.

Authors:  Aaron J Tyznik; Shilpi Verma; Qiao Wang; Mitchell Kronenberg; Chris A Benedict
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

4.  Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues.

Authors:  Ahmad S Altiti; Xiaojing Ma; Lixing Zhang; Yi Ban; Richard W Franck; David R Mootoo
Journal:  Carbohydr Res       Date:  2017-03-06       Impact factor: 2.104

5.  Design, Synthesis, and Immunological Evaluation of Benzyloxyalkyl-Substituted 1,2,3-Triazolyl α-GalCer Analogues.

Authors:  Yogesh Kumar Verma; Bonam Srinivasa Reddy; Mithun S Pawar; Debabrata Bhunia; Halmuthur M Sampath Kumar
Journal:  ACS Med Chem Lett       Date:  2015-12-10       Impact factor: 4.345

Review 6.  The Alpha and Omega of Galactosylceramides in T Cell Immune Function.

Authors:  Alysia M Birkholz; Amy R Howell; Mitchell Kronenberg
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

7.  Antigen-dependent versus -independent activation of invariant NKT cells during infection.

Authors:  Keli L Holzapfel; Aaron J Tyznik; Mitchell Kronenberg; Kristin A Hogquist
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

Review 8.  Recognition of CD1d-restricted antigens by natural killer T cells.

Authors:  Jamie Rossjohn; Daniel G Pellicci; Onisha Patel; Laurent Gapin; Dale I Godfrey
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

Review 9.  Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.

Authors:  Enrico Girardi; Dirk M Zajonc
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

10.  Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.

Authors:  Sandrine Aspeslagh; Marek Nemčovič; Nora Pauwels; Koen Venken; Jing Wang; Serge Van Calenbergh; Dirk M Zajonc; Dirk Elewaut
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.